相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Coronary Calcifications in End-Stage Renal Disease Patients: A New Link between Osteoprotegerin, Diabetes and Body Mass Index?
Giuseppe Cianciolo et al.
BLOOD PURIFICATION (2010)
The emerging pleiotrophic role of adipokines in the uremic phenotype
Juan Jesus Carrero et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2010)
Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis
Antonio Carlos Cordeiro et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Persistent Inflammation as a Catalyst for Other Risk Factors in Chronic Kidney Disease: A Hypothesis Proposal
Juan Jesus Carrero et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Fetuin-A and Change in Body Composition in Older Persons
Joachim H. Ix et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Abdominal Obesity and All-Cause and Cardiovascular Mortality in End-Stage Renal Disease
Maurizio Postorino et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification
Mhairi K. Sigrist et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Is fetuin-A/alpha 2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?
Jonas Axelsson et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults
Natascia Di Iorgi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue
John N. Fain et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
The bone-adipose axis in obesity and weight loss
J. Gomez-Ambrosi et al.
OBESITY SURGERY (2008)
Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice
Mathieu Ferron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Expression and regulation of osteoprotegefin in adipose tissue
Juan-Ji An et al.
YONSEI MEDICAL JOURNAL (2007)
Protein array reveals differentially expressed proteins in subcutaneous adipose tissue in obesity
Martina Skopkova et al.
OBESITY (2007)
Plasma osteopontin levels and expression in adipose tissue are increased in obesity
Javier Gomez-Ambrosi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Endocrine regulation of energy metabolism by the skeleton
Na Kyung Lee et al.
CELL (2007)
The influence of weight loss on serum osteoprotegerin concentration in obese Perimenopausal women
Michal Holecki et al.
OBESITY (2007)
Vascular calcifications:: Pathogenesis, management, and impact on clinical outcomes
Jorge B. Cannata-Andia et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways
Yusuke Shinoda et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects
DV Anand et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Plasma osteoprotegerin is associated with mortality in hemodialysis patients
Marion Morena et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Polymorphism of the AHSG gene is associated with increased adipocyte β2-adrenoceptor function
C Lavebratt et al.
JOURNAL OF LIPID RESEARCH (2005)
Low fetuin-A levels are associated with cardiovascular death:: Impact of variations in the gene encoding fetuin
P Stenvinkel et al.
KIDNEY INTERNATIONAL (2005)
AHSG gene variant is associated with leanness among Swedish men
C Lavebratt et al.
HUMAN GENETICS (2005)
Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors
DV Barreto et al.
KIDNEY INTERNATIONAL (2005)
Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women
ES Oh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients
K Nitta et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease
A Marchlewska et al.
KIDNEY INTERNATIONAL (2004)
Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis:: a cross-sectional study
M Ketteler et al.
LANCET (2003)
α2-HS glycoprotein/fetuin, a transforming growth factor-β/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling
M Szweras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling
JO Gordeladze et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure
JJ Kazama et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
P Ducy et al.
CELL (2000)
分享论文
